跳至主要内容
临床试验/NCT03955770
NCT03955770已完成4 期

Effects of High Flow Oxygen Therapy on Exercise Performance in Patients With Chronic Obstructive Pulmonary Disease. A Randomized, Controlled Trial.

University of Zurich1 个研究点 分布在 1 个国家目标入组 79 人开始时间: 2019年5月20日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
79
试验地点
1
主要终点
Exercise endurance time in seconds

研究概览

简要总结

This will be a randomized, cross-over trial evaluating the efficacy of nasal high-flow oxygen therapy (HFOT) vs. low-flow oxygen therapy (LFOT) on cycling endurance in patients with chronic obstructive pulmonary disease (COPD).

详细描述

This will be a randomized, cross-over trial evaluating the efficacy of nasal HFOT vs. LFOT on cycling endurance in patients with COPD. Each patient will perform two constant load cycling exercise tests to exhaustion using HFOT and LFOT on two consecutive days, respectively, according to randomization. The load of the cycle ergometer will be set at 75% of the individually estimated maximum work rate (Wmax). During exercise tests, LFOT will be provided by a standard nasal cannula at a flow rate of 3 L/min using an oxygen concentrator. HFOT will be applied by a dedicated large bore nasal cannula at a flow rate 60 L/min, FiO2 45%, temperature 32 °C, using a HFOT device.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
35 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Men and women, 35 to 75 years of age, with moderate to severe COPD, (FEV1/FVC <0.7, FEV1 40-80% predicted, resting SpO2 ≥92%, PaCO2 <6 kPa at 760 m) who live <800 m will be invited.

排除标准

  • •COPD exacerbation, very severe COPD with hypoxemia (FEV1/FVC <0.7, FEV1 <40% predicted, oxygen saturation on room air <92%), current heavy smoking (>20 cigarettes per day), comorbidities such as uncontrolled cardiovascular disease, internal, neurologic, rheumatologic or psychiatric disease that interfere with protocol compliance.

研究组 & 干预措施

HFOT first then LFOT

Experimental

干预措施: High-flow oxygen therapy (HFOT) (Combination Product)

HFOT first then LFOT

Experimental

干预措施: Low-flow oxygen therapy (LFOT) (Combination Product)

LFOT first then HFOT

Experimental

干预措施: High-flow oxygen therapy (HFOT) (Combination Product)

LFOT first then HFOT

Experimental

干预措施: Low-flow oxygen therapy (LFOT) (Combination Product)

结局指标

主要结局

Exercise endurance time in seconds

时间窗: HFOT on day 1 vs. LFOT on day 2 or vice versa, according to randomization

Difference in the exercise endurance time between HFOT vs. LFOT during a constant load exercise test at 75% of the maximal work capacity.

次要结局

  • Dyspnea sensation(HFOT on day 1 vs. LFOT on day 2 or vice versa, according to randomization)
  • Arterial blood gases(HFOT on day 1 vs. LFOT on day 2 or vice versa, according to randomization)
  • Subjective leg fatigue sensation(HFOT on day 1 vs. LFOT on day 2 or vice versa, according to randomization)
  • Heart rate in bpm(HFOT on day 1 vs. LFOT on day 2 or vice versa, according to randomization)
  • Arterial blood pressure in mmHg(HFOT on day 1 vs. LFOT on day 2 or vice versa, according to randomization)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验